|
|
 |
I'd like to thank you and your staff personally for taking my healthcare issues in your capable hands and hearts. I appreciate all you have done. Thank you from the bottom of my "cancer free" heart.
- Scottsdale Center patient
The staff here is very compassionate and caring, efficient and knowledgeable.
- Apache Junction Center patient
I am very impressed with medical staff who developed and executed my oncology treatment plan. For this I am dearly grateful for the important work you all do to save lives.
- Arrowhead Center patient
I never minded going to the clinic every day throughout my treatments because I felt the love and caring there. It was a serious event, but done in a professional manner. Thanks so much.
- East Valley Center patient
Everyone was compassionate, concerned, and took wonderful care of me. All my problems were solved and all my questions answered. Great experience.
-Deer Valley Center patient
|
|
|
|
|
|
|
|
|
 David C. Beyer, MD, FASTRO, FACRO, FACR, is Vice President of Arizona Oncology Services, Inc. He serves on the Board of Directors for the American Society of Therapeutic Radiology & Oncology (ASTRO), is on the Board of Chancellors with the American College of Radiation Oncology (ACRO), and is an Editorial Board Member of the Journal of Brachytherapy. He is past president of the American Brachytherapy Society.
Dr. Beyer earned his medical degree from the University of Arizona, College of Medicine after completing a degree in electrical engineering from Massachusetts Institute of Technology. He joined Arizona Oncology Services in 1985, after serving consecutive residencies in both internal medicine and radiation oncology at the University of Arizona Health Sciences Center and University of California, Los Angeles. He is a member of Alpha Omega Alpha Honorary Society. Dr. Beyer is a Fellow of the American College of Radiation Oncology (ACRO), the American College of Radiology (ACR), and the American Society for Therapeutic Radiology and Oncology (ASTRO).
 Dr. Beyer’s primary clinical interests focus on prostate cancer and prostate Brachytherapy including seed implants, and high dose rate (HDR) brachytherapy. He has comprehensive experience in intensity modulated radiation therapy (IMRT) and image guidance radiation therapy (IGRT). He is a frequent lecturer at implant training courses and medical meetings, and has published extensively the AOS results in prostate treatment. Dr. Beyer is board certified by the American Board of Radiology in Radiation Therapy and the American Board of Internal Medicine. Dr. Beyer is based at AOS - Scottsdale Center and AOS - Arrowhead Center.
|
|
|
| Activities and Publications
|
|
|
|
|
2004 to Present -- prior materials archived.
ACR appropriateness criteria on external beam radiation therapy treatment planning for clinically localized prostate cancer expert panel on radiation oncology--prostate.
Michalski JM, Roach M 3rd, Merrick G, Anscher MS, Beyer DC, Lawton CA, Lee WR, Pollack A, Rosenthal SA, Vijayakumar S, Carroll PR.
Int J Radiat Oncol Biol Phys. 2009 Jul 1;74(3):667-72. Epub 2009 Apr 20. Review. No abstract available.
PMID: 19386445 [PubMed - indexed for MEDLINE]
American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) Practice Guidelines for Intensity-Modulated Radiation Therapy (IMRT).
Hartford AC, Palisca MG, Eichler TJ, Beyer DC, Devineni VR, Ibbott GS, Kavanagh B, Kent JS, Rosenthal SA, Schultz CJ, Tripuraneni P, Gaspar LE; American Society for Therapeutic Radiology and Oncology; American College of Radiology.
Int J Radiat Oncol Biol Phys. 2009 Jan 1;73(1):9-14. No abstract available.
PMID: 19100920 [PubMed - indexed for MEDLINE]
The role of physicians and medical organizations in the development, analysis, and implementation of health care policy.
Beyer DC, Mohideen N.
Semin Radiat Oncol. 2008 Jul;18(3):186-93.
PMID: 18513628 [PubMed - indexed for MEDLINE]
Interstitial implant alone or in combination with external beam radiation therapy for intermediate-risk prostate cancer: a survey of practice patterns in the United States.
Frank SJ, Grimm PD, Sylvester JE, Merrick GS, Davis BJ, Zietman A, Moran BJ, Beyer DC, Roach M 3rd, Clarke DH, Stock RG, Robert Lee W, Michalski JM, Wallner KE, Hurwitz M, Potters L, Kuban DA, Prestidge BR, Vera R, Hathaway S, Blasko JC.
Brachytherapy. 2007 Jan-Mar;6(1):2-8.
PMID: 17284379 [PubMed - indexed for MEDLINE]
Multi-institutional analysis of long-term outcome for stages T1-T2 prostate cancer treated with permanent seed implantation.
Zelefsky MJ, Kuban DA, Levy LB, Potters L, Beyer DC, Blasko JC, Moran BJ, Ciezki JP, Zietman AL, Pisansky TM, Elshaikh M, Horwitz EM.
Int J Radiat Oncol Biol Phys. 2007 Feb 1;67(2):327-33. Epub 2006 Nov 2.
PMID: 17084558 [PubMed - indexed for MEDLINE]
Comparison of biochemical failure definitions for permanent prostate brachytherapy.
Kuban DA, Levy LB, Potters L, Beyer DC, Blasko JC, Moran BJ, Ciezki JP, Zietman AL, Zelefsky MJ, Pisansky TM, Elshaikh M, Horwitz EM.
Int J Radiat Oncol Biol Phys. 2006 Aug 1;65(5):1487-93. Epub 2006 Jun 5.
PMID: 16750326 [PubMed - indexed for MEDLINE]
Impact of short course hormonal therapy on overall and cancer specific survival after permanent prostate brachytherapy.
Beyer DC, McKeough T, Thomas T.
Int J Radiat Oncol Biol Phys. 2005 Apr 1;61(5):1299-305.
PMID: 15817331 [PubMed - indexed for MEDLINE]
|
|
|